NCT01106508 A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01105507 The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada Status COMPLETED Phase PHASE3
NCT01103050 A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine Status COMPLETED Phase PHASE2
NCT01103037 Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma Status TERMINATED Phase PHASE2
NCT01098838 Safety and Efficacy of LCL161 in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01097096 Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients Status COMPLETED Phase PHASE2
NCT01095250 Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis Status TERMINATED Phase PHASE3
NCT01094704 Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT01092533 Myfortic for the Treatment of Non-infectious Intermediate Uveitis Status COMPLETED Phase PHASE3
NCT01090973 Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Status TERMINATED Phase PHASE2
NCT01090323 Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). Status COMPLETED Phase PHASE2
NCT01090310 Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis Status TERMINATED Phase PHASE3
NCT01089127 Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01088880 Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever Status COMPLETED Phase PHASE2
NCT01084330 Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT01083602 Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01082367 Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years Status COMPLETED Phase PHASE3
NCT01080768 Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension Status TERMINATED Phase PHASE2
NCT01080131 Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. Status COMPLETED Phase PHASE3